FDA Adverse Event Other Summary report: N

AVANTA FLUID MANAGEMENT SYSTEM

MDR report key: 3783533 · Received April 16, 2014

Report

Report Number
2520313-2014-00021
Event Type
Other
Date Received
April 16, 2014
Date of Event
March 11, 2014
Report Date
March 27, 2014
Manufacturer
MEDRAD
Product Code
DXT
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
TD
Reporter Occupation
OTHER

Narratives

Additional Manufacturer Narrative · 1

A BAYER R AND I SERVICE ENGINEER PERFORMED AN INJECTOR CHECKOUT OF THE AVANTA FLUID MANAGEMENT SYSTEM ON (B)(6) 2014 AND FOUND IT WAS FUNCTIONING TO SPECIFICATION. THE DISPOSABLES FROM THE ALLEGED INCIDENT WERE DISCARDED AND NOT AVAILABLE FOR EVALUATION. THE SITE PROVIDED LOT NUMBERS THAT WERE IN USE DURING THE ALLEGED INCIDENT. TESTING OF RETAIN SAMPLES SHOWED THE PRODUCT PERFORMED TO SPECIFICATION. THE AVANTA FLUID MANAGEMENT SYSTEM HAS BEEN IN USE DAILY AT THE SITE SINCE THE REPORTED OCCURRENCE. ADDITIONAL APPLICATIONS TRAINING WAS PERFORMED ON (B)(6) 2014.

Description of Event or Problem · 1

THE SITE REPORTED THE FOLLOWING TO A BAYER R AND I REPRESENTATIVE: A (B)(6) MALE PT WITH A KNOWN CARDIAC CONDITION, DIABETES, AND HYPERTENSION UNDERWENT A CORONARY ANGIOGRAM AND SUFFERED AN AIR INJECTION WHILE CONNECTED TO THE AVANTA FLUID MANAGEMENT SYSTEM. AN INDETERMINATE AMOUNT OF AIR WAS VISUALIZED IN THE LEFT CORONARY ARTERY FOLLOWING A TEST INJECTION. THE PT BECAME BRADYCARDIC AND SUFFERED A CARDIAC ARREST. THE PT REQUIRED MEDICAL INTERVENTION INCLUDING CHEST COMPRESSIONS, ATROPINE AND ADRENALINE. THE PT RECOVERED AND WAS DISCHARGED TWO DAYS FOLLOWING THE PROCEDURE. NO FURTHER TREATMENT WAS REQUIRED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
233885 AVANTA FLUID MANAGEMENT SYSTEM ANGIOGRAPHIC INJECTOR DXT MEDRAD AVA 500 PEDL

Patients

Seq Age Sex Outcome Treatment
1 47 YR Required Intervention